Abstract: An excreta disposal device is provided, which includes a main body formed with a first disposal space opened in a hip direction of a human body to receive excreta discharged from the human body, and has a storage space formed therein. A male module, in which a second disposal space configured to receive urine discharged from the human body, is formed inside, and an opening unit opened to face the human body of the user is formed on one side of the second disposal space. The second disposal space is formed to be capable of inserting at least a part of male genitalia and is provided in the main body. A suction port is provided in the storage space and communicates with at least one of the first disposal space and the second disposal space to discharge excreta to the outside of the main body.

Abstract: Disclosed herein is a refrigerator may include a cabinet, a door which opens a front of the cabinet, a panel disposed in front of the door, and a coupling unit which couples the panel with the door. And the coupling unit may include a first adjustor provided to adjust a position of the panel in a left and right direction, a second adjustor provided to adjust a position of the panel in an up and down direction, and a third adjustor provided to adjust a position of the panel in a front and rear direction.

Abstract: Disclosed herein is a refrigerator may include a cabinet, a door which opens a front of the cabinet, a panel disposed in front of the door, and a coupling unit which couples the panel with the door. And the coupling unit may include a first adjustor provided to adjust a position of the panel in a left and right direction, a second adjustor provided to adjust a position of the panel in an up and down direction, and a third adjustor provided to adjust a position of the panel in a front and rear direction.

Abstract: Provided are novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition including the same at a pharmaceutically effective amount. The selective androgen receptor agonists according to the present invention act on androgen receptors to increase androgen activity, thereby being usefully applied as a therapeutic and prophylactic agent for diseases or conditions, of which symptoms may be improved or may respond to treatment by increased activities of androgen receptors, namely, a variety of hormone-related diseases in male and female, muscle wasting disorders, osteoporosis, etc.

Abstract: An excreta disposal device is provided, which includes a main body formed with a first disposal space opened in a hip direction of a human body to receive excreta discharged from the human body, and has a storage space formed therein. A male module, in which a second disposal space configured to receive urine discharged from the human body, is formed inside, and an opening unit opened to face the human body of the user is formed on one side of the second disposal space. The second disposal space is formed to be capable of inserting at least a part of male genitalia and is provided in the main body. A suction port is provided in the storage space and communicates with at least one of the first disposal space and the second disposal space to discharge excreta to the outside of the main body.

Abstract: Provided are novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition including the same at a pharmaceutically effective amount. The selective androgen receptor agonists according to the present invention act on androgen receptors to increase androgen activity, thereby being usefully applied as a therapeutic and prophylactic agent for diseases or conditions, of which symptoms may be improved or may respond to treatment by increased activities of androgen receptors, namely, a variety of hormone-related diseases in male and female, muscle wasting disorders, osteoporosis, etc.

Abstract: A refrigerator may prevent an internal door from being opened together by an inertial force when an external door is opened, and may also prevent the external door from being opened together by an inertial force when the internal door is opened. The refrigerator includes a main body, a storage chamber provided in the main body so that a front surface thereof is opened, an internal door rotatably provided at a front surface of the main body so as to open and close the storage chamber and having an opening part in which a plurality of door guards are provided, an external door rotatably provided at a front surface of the internal door so as to open and close the opening part, and an internal door opening prevention device allowing or preventing opening of the internal door according to whether the external door is opened or closed.

Abstract: The present invention relates to a system and method for pathway construction, including an advance information database for storing an entity name of protein, diseases, compounds, symptoms, enzymes, medicines, diseases, place and/or pathway; an entity recognition unit for recognizing entities from an input document using the advance information database; a relation recognition unit for extracting context between the recognized entities based on the pre-stored context pattern information, and recognizing a relation between the entities by normalizing the extracted context; a relation event generating unit for performing a web search for the recognized entities to collect a document including the entities and information on the points in cells of the entities, and generating a relation event based on the collected information; and a pathway generating unit for displaying relevant entities at the relevant points in the cells based on the recognized relation event to generate a pathway.

Abstract: A refrigerator may prevent an internal door from being opened together by an inertial force when an external door is opened, and may also prevent the external door from being opened together by an inertial force when the internal door is opened. The refrigerator includes a main body, a storage chamber provided in the main body so that a front surface thereof is opened, an internal door rotatably provided at a front surface of the main body so as to open and close the storage chamber and having an opening part in which a plurality of door guards are provided, an external door rotatably provided at a front surface of the internal door so as to open and close the opening part, and an internal door opening prevention device allowing or preventing opening of the internal door according to whether the external door is opened or closed.

Abstract: A cutting insert has a top surface, a bottom surface, a plurality of side surfaces that connect the top and bottom surfaces. The side surfaces form an obtuse angle with the bottom surface as well as an acute angle with the top surface. The side surfaces include a first side surface and a second side surface, which form an obtuse angle with each other when seen from the above. A main cutting edge is formed at an intersection between the first side surface and the top surface. An inclined cutting edge, which is only for ramp milling, and a minor cutting edge are formed at an intersection between the second side surface and the top surface. An obtuse angle, which the second side surface forms with the bottom surface, is greater than that which the first side surface forms with the bottom surface.

Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: A cutting insert has a top surface, a bottom surface, a plurality of side surfaces that connect the top and bottom surfaces. The side surfaces form an obtuse angle with the bottom surface as well as an acute angle with the top surface. The side surfaces include a first side surface and a second side surface, which form an obtuse angle with each other when seen from the above. A main cutting edge is formed at an intersection between the first side surface and the top surface. An inclined cutting edge, which is only for ramp milling, and a minor cutting edge are formed at an intersection between the second side surface and the top surface. An obtuse angle, which the second side surface forms with the bottom surface, is greater than that which the first side surface forms with the bottom surface.

Abstract: A display apparatus including a display driver. The data driver includes a converter to receive and convert image data in digital form into data voltages in analog form, and to provide the data voltages to output buffers. The output buffers receive and buffer the data voltages based on bias voltages generated as part of a feedback path between a bias voltage control circuit and the output buffers. The data voltages are provided to a display part. Before the data voltages output from the output buffers are provided to the display part, the bias voltage control part receives data voltage from the output buffers to count a slew rate of the data voltage, and varies the voltage level of the bias voltage based on the counted result of the slew rate, thereby providing feedback to the output buffers. Accordingly, differences of the slew rate between the data voltages output from the output buffers may be decreased.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.